로딩 중…
StockDiggingStockDigging

Vistos Co., Ltd

419540· KOSDAQ
₩3,180+0.32%
2026-06-19

Price Chart

Vistos Co., Ltd-60.20%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap14.62B KRW
Revenue16.36B KRW
Net Income-454.3M KRW
Total Assets25.85B KRW
Net Assets17.61B KRW
Employees69
Value
P/B0.83x
P/S0.89x
FCF Yield-14.83%
Profitability
ROE-2.58%
ROA-1.76%
Op. Margin-5.56%
Revenue Growth-19.94%
Earnings Growth-194.40%
Financial Health
Debt Ratio146.80%
Total Debt3.12B KRW
FCF-2.17B KRW
Cash3.78B KRW
Current Ratio2.03x
Dividend
Div. Growth0.00%
Performance
1Y Return-60.20%
1M Return-27.48%
From 52W High-72.35%
1Y MDD-78.67%
Trading
Volume41,264 shares
Foreign Own.0.89%
Per Share
EPS-99 KRW
BPS3,932 KRW

Company Info

CEO 이선종
Employees 69
Founded 2001
HQ 경기도 성남시, KR

Bistos, established in 2001, specializes in manufacturing medical devices, particularly for fetal and neonatal care, including fetal monitors, jaundice therapy devices, and incubators, and was listed on KOSDAQ in 2022. Over 90% of its sales come from exports to over 120 countries. The company is expanding into home medical devices like breast pumps and thermometers, patient monitors, and aims to become a leader in biosignal technology by exploring ADHD/dementia treatment and wearable healthcare. Bistos is headquartered in Gyeonggi-do, Seongnam-si.